Benchmark International is delighted to announce the sale of Contronics Limited (Contronics), which has been acquired by two private investors, for an undisclosed fee.
Contronics designs, manufactures, installs and maintains an innovative range of environmental monitoring systems from its premises in Congleton. Its unique systems help protect valuable products and materials in healthcare settings such as tissue banks, stem cell laboratories, pharmaceutical manufacturing and research facilities in the UK and overseas.
The new Managing Director is a Doctor of Veterinary Medicine whose career has seen her work with GlaxoSmithKline and other biotech companies. The additional investor, and new Chairman, has successfully managed several technology start-ups.
Along with the shareholders of Contronics, the acquirers hold a similar vision for the future of the company: continuing to develop and expand the existing product range of laboratory monitoring systems and exploring diversification opportunities into other related healthcare applications.
The new investors will take a 15 year lease on the premises and all the established team will continue to be employed.
All at Benchmark International are pleased that the shareholders have been paired with suitable acquirers to maintain the company’s financial stability, excellent reputation and long-term customer relationships.